Rchr
J-GLOBAL ID:201901012211535338   Update date: Sep. 20, 2024

Uraki Ryuta

ウラキ リュウタ | Uraki Ryuta
Affiliation and department:
Other affiliations (1):
Research field  (4): Zoological sciences ,  Immunology ,  Virology ,  Veterinary medicine
Research keywords  (7): SARS-CoV-2 ,  免疫学 ,  節足動物 ,  ジカウイルス ,  インフルエンザウイルス ,  感染症 ,  ウイルス
Research theme for competitive and other funds  (6):
  • 2022 - 2024 新規治療法を目指したSARS-CoV-2感染病態における制御性T細胞の寄与の解明
  • 2020 - 2022 Contribution of regulatory T cells in the establishment and maintenance of persistent hepatitis B virus infection
  • 2019 - 2022 Mechanisms of autoimmune diseases triggered by infectious foci and treatment strategies
  • 2019 - 2021 Analysis of host immune systems in the onset of HBV-related chronic hepatitis / liver cancer
  • 2017 - 2019 ジカウイルス感染・伝播を促進するネッタイシマカ唾液腺分泌蛋白質の同定と機能解析
Show all
Papers (65):
  • Maki Kiso, Ryuta Uraki, Seiya Yamayoshi, Masaki Imai, Yoshihiro Kawaoka. Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals. iScience. 2024. 27. 9. 110729-110729
  • Peter J Halfmann, Kiyoko Iwatsuki-Horimoto, Makoto Kuroda, Yuichiro Hirata, Seiya Yamayoshi, Shun Iida, Ryuta Uraki, Mutsumi Ito, Hiroshi Ueki, Yuri Furusawa, et al. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. Communications biology. 2024. 7. 1. 331-331
  • Ryuta Uraki, Masaki Imai, Mutsumi Ito, Seiya Yamayoshi, Maki Kiso, Nao Jounai, Kazuki Miyaji, Kiyoko Iwatsuki-Horimoto, Fumihiko Takeshita, Yoshihiro Kawaoka. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. NPJ vaccines. 2024. 9. 1. 4-4
  • Ryuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Mutsumi Ito, Shiho Chiba, Yuko Sakai-Tagawa, Masaki Imai, Yukie Kashima, Michiko Koga, et al. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo. Cell reports. 2023. 42. 12. 113580-113580
  • Ryuta Uraki, Mutsumi Ito, Maki Kiso, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Yuko Sakai-Tagawa, Masaki Imai, Michiko Koga, Shinya Yamamoto, Eisuke Adachi, et al. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate. iScience. 2023. 26. 11. 108147-108147
more...
MISC (3):
Patents (1):
  • モノクローナル抗体又はその抗原結合フラグメント及びその使用
Education (4):
  • 2012 - 2015 The University of Tokyo
  • 2010 - 2012 The University of Tokyo
  • 2008 - 2010 The University of Tokyo
  • 2006 - 2008 The University of Tokyo Science II
Professional career (1):
  • 博士(生命科学) (東京大学)
Work history (6):
  • 2021/04 - 現在 The University of Tokyo The Institute of Medical Science
  • 2021/04 - 現在 National Center for Global Health and Medicine
  • 2019/03 - 2021/03 Nagoya City University
  • 2017/07 - 2019/02 Yale University Section of Infectious Diseases, School of Medicine
  • 2015/07 - 2017/06 Yale School of medicine Section of Infectious Diseases, School of Medicine
Show all
Awards (8):
  • 2024/04 - 文部科学省 文部科学大臣表彰 若手科学者賞 RNAウイルスの性状解析及び新規予防法開発に関する研究
  • 2023/09 - 日本ウイルス学会 杉浦奨励賞 RNAウイルスの病原性解析と新規予防法の開発
  • 2023/03 - 国立国際医療研究センター 箱根山賞
  • 2023/02 - Best Presentation Award Winner 2022
  • 2019/12 - 名古屋市立大学医学会 名古屋市立大学医学会奨励賞
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page